# Bafna Pharmaceuticals Ltd (BAFNAPH)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹135.03
Day Change: -0.6%
52W High: ₹202.06
52W Low: ₹72.01
Market Cap: ₹319 Cr

## Valuation
P/E: 32.93
P/B: 3.5
EPS: ₹4.09
Book Value: ₹38.54
Dividend Yield: 0%

## Returns
1Y Return: -14.55%

## Profitability
ROE: 0%
ROCE: 131.32%
Debt/Equity: 0.36
Revenue Growth: 15.4%
Profit Growth: 95%
EBITDA Margin: 10.99%
Operating Margin: 3.87%

## About
Bafna Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Bafna Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Clarification On Price Movement
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Clarification On Price Movement

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-17T21:24:36.968Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:36.968Z
Quant Updated: 2026-05-17T21:24:36.968Z
Sentiment Updated: 2026-05-17T21:24:36.968Z
Financials Status: current
Financials Updated: 2026-05-19T14:30:14.589Z
Financials Last Attempt: 2026-05-19T14:30:14.589Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹145.86 Cr
Operating Profit: ₹6.96 Cr (OPM 4.77%)
Net Profit: ₹4.15 Cr
Tax: ₹0 Cr

## Annual P&L History
FY25: Rev ₹145.86Cr | PAT ₹4.15Cr | OPM 4.77%
FY24: Rev ₹152.47Cr | PAT ₹7.35Cr | OPM 4.28%
FY23: Rev ₹115.35Cr | PAT ₹11.34Cr | OPM 10.46%

## Balance Sheet (FY25)
Total Assets: ₹153.08 Cr
Total Liabilities: ₹68.27 Cr
Borrowings: ₹28.2 Cr
Cash: ₹3.43 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Bansilal Mahaveer Chand Bafna, Chief Executive Officer
- Melagiri  Sridhar, Chief Financial Officer
- A.  Mohanachandran, Company Secretary & Compliance Officer
- Vinayak Dinesh Dendukuri, Whole-Time Director of Quality & Whole-Time Director
- Shanmugam  Hemalatha, Whole-Time Director

---
Source: rupiya.io/stocks/bafnaph
Disclaimer: For research and education only. Not investment advice.